Physician

Michelle Nunes Caravaglio, MD

According to 2025 Medicare claims, Michelle Caravaglio, MD (NPI: 1992245450) practices epileptologists in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is BAPTIST NEUROLOGY INC (NPI: 1598995599; TIN: 262665620) and primary practice location at 32250-3206.

Caravaglio's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 284 traditional Medicare patients, billed 588 HCPCS/CPT codes, and received $69,381 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 872 prescription claims across 186 beneficiaries totaling $214,647 in drug costs, led by Aptiom (Eslicarbazepine Acetate). Open Payments data shows 85 records totaling $2,100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,685 to $214,647. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$35K$69K2023 Medicare payment: $2,464 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $69,381 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20231322$2,464
2024284588$69,381

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$107K$215K2017 Drug cost: $2,685 (USD; Tot_Drug_Cst)2018 Drug cost: $6,460 (USD; Tot_Drug_Cst)2019 Drug cost: $6,021 (USD; Tot_Drug_Cst)2020 Drug cost: $10,261 (USD; Tot_Drug_Cst)2021 Drug cost: $11,185 (USD; Tot_Drug_Cst)2023 Drug cost: $49,487 (USD; Tot_Drug_Cst)2024 Drug cost: $214,647 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172575$2,685
20183696$6,460
20192147$6,021
202024107$10,261
20211882$11,185
2022N/RN/RN/R
20232971$49,487
2024186872$214,647

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95816Measurement of brain wave activity (eeg), awake and drowsy5959$169
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more107107$163
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more103134$133
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5369$95
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's6772$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AptiomEslicarbazepine Acetate13390$33,216
XcopriCenobamate25721$29,069
Nurtec OdtRimegepant Sulfate14481$26,352
BriviactBrivaracetam13390$18,083
Aimovig AutoinjectorErenumab-Aooe22646$16,457

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$2,100ARGENX US, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michelle Nunes Caravaglio, MD?

Tedicare shows public-source Medicare data for Michelle Nunes Caravaglio, MD (NPI 1992245450), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michelle Nunes Caravaglio, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michelle Nunes Caravaglio, MD?

Michelle Nunes Caravaglio, MD is linked to BAPTIST NEUROLOGY INC (billing NPI 1598995599) in the available physician profile data.

Does Michelle Nunes Caravaglio, MD have Open Payments data?

Michelle Nunes Caravaglio, MD has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.